HEYAN BIOTECH
Heyan Biotech is a national biotech industry base, provides for target based in vitro pharmacodynamic screening and early pharmacological pharmacodynamic evaluation services in early drug discovery.
HEYAN BIOTECH
Industry:
Biotechnology Health Care Pharmaceutical
Address:
Wuhan, Hubei, China
Country:
China
Status:
Active
Similar Organizations
LabSkinPro
LabSkinPro provides research and product development service to regional pharmaceutical and cosmetic industries.
Premas Biotech
Premas Biotech provides therapeutics and vaccines development apps, manufacturing, cell line, process and analytical development services.
Wuhan Hongren Biopharmaceutical
Wuhan Hongren Biopharmaceutical is provides high-tech biomedical research and development technical services.
More informations about "Heyan Biotech"
Frontage Expands Early Drug Discovery Services through the …
September 8, 2021 Frontage Expands Early Drug Discovery Services through the Acquisition of Heyan Biotech. Shanghai, China, August 31st, 2021 – Frontage Shanghai announced the …See details»
Heyan Biotech - Funding, Financials, Valuation & Investors
Heyan Biotech provides for target based in vitro pharmacodynamic screening and early pharmacological pharmacodynamic evaluation services. Search Crunchbase. ... How much …See details»
Frontage Expands Early Drug Discovery Services through the …
Sep 8, 2021 Heyan Biotech will further expand its service capacity in drug discovery to enhance Frontage's one-stop service capacity and capability in the field of drug discovery and …See details»
Frontage Laboratories acquires Heyan Biotech - Crunchbase
Heyan Biotech Heyan Biotech provides for target based in vitro pharmacodynamic screening and early pharmacological pharmacodynamic evaluation services. Acquiring Organization: …See details»
Heyan Biomedical Technology - Products, Competitors, Financials ...
About Heyan Biomedical Technology. Heyan Biotech, located in Wuhan Optics Valley, a national biotech industry base, provides target-based in vitro pharmacodynamic screening and early …See details»
Frontage Shanghai Acquires Wuhan Heyan Biomedical
Sep 9, 2021 Frontage Shanghai has acquired 70% equity interest in Wuhan Heyan Biomedical Technology Co., Ltd. Heyan Biotech, located in Wuhan Optics Valley, national biotech industry base, provides for target based in vitro …See details»
Frontage Expands Early Drug Discovery Services through the …
Frontage Shanghai announced the acquisition of 70% equity interest in Wuhan Heyan Biomedical Technology Co., Ltd. Heyan BiotechSee details»
Frontage Acquires Heyan Biotech Expanding Early Drug …
Sep 14, 2021 Frontage Shanghai announced the acquisition of 70% equity interest in Wuhan Heyan Biomedical Technology Co., Ltd. ("Heyan Biotech") Heyan Biotech, located in Wuhan Optics Valley, national biotech industry …See details»
Frontage Expands Early Drug Discovery Services Through The …
Heyan Biotech will further expand its service capacity in drug discovery to enhance Frontage's one-stop service capacity and capability in the field of drug discovery and development." …See details»
Frontage Expands Early Drug Discovery Services through the …
Sep 8, 2021 Frontage Shanghai announced the acquisition of 70% equity interest in Wuhan Heyan Biomedical Technology Co., Ltd. (“Heyan Biotech”) Heyan Biotech, located in Wuhan …See details»
Frontage Expands Early Drug Discovery Services through the …
Sep 9, 2021 Frontage Shanghai announced the acquisition of 70% equity interest in Wuhan Heyan Biomedical Technology Co., Ltd. ("Heyan Biotech") Heyan Biotech, located in Wuhan …See details»
Frontage Acquires Majority Stake in Wuhan Heyan Biomedical, a …
Sep 9, 2021 Frontage Shanghai, a division of US-China CRO Frontage Holdings, acquired a 70% stake in Wuhan Heyan Biomedical Technology, a discovery CRO. Heyan offers target …See details»
Guangdong Heyan Biotechnology Co., Ltd. - Drug pipelines, …
Last update 19 Sep 2024. Guangdong Heyan Biotechnology Co., Ltd. Private Company |See details»
Guangzhou Heyan Biotechnology Co., Ltd.: Drug pipelines, Patents ...
Jul 11, 2023 Explore Guangzhou Heyan Biotechnology Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Frontage Expands Early Drug Discovery Services Through the …
Sep 16, 2021 Frontage Shanghai announced the acquisition of 70% equity interest in Wuhan Heyan Biomedical Technology Co., Ltd. (“Heyan Biotech”) Heyan Biotech, located in Wuhan …See details»
HEYAN - Crunchbase Company Profile & Funding
Guangzhou Heyan Big Data Technology Co is a big data analysis and mining mobile game distribution platform. ... BioSpace — Frontage Expands Early Drug Discovery Services through …See details»
Shanghai Heyan Biotechnology Co., Ltd.: Drug pipelines, Patents ...
Jun 19, 2023 0 Patents (Medical) associated with Shanghai Heyan Biotechnology Co., Ltd. Login to view more data. Pipeline. Pipeline Snapshot as of 19 Jun 2023. No pipeline posted. Login to …See details»
Series A - Heyan Biotech - 2020-11-26 - Crunchbase
Organization Name . Heyan Biotech . Announced Date Nov 26, 2020; Funding Type ...See details»
How a U of A spinoff company beat the odds to create a new kind …
19 hours ago University of Alberta spinoff Pacylex has spent 12 years pushing its first-in-class cancer treatment forward from a research lab idea to the stage of Phase 2 human trials with …See details»